MedPath

The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease

Not yet recruiting
Conditions
Diabetic Kidney Disease
Extracellular Matrix Alteration
Interventions
Other: no intervention
Registration Number
NCT06049550
Lead Sponsor
RenJi Hospital
Brief Summary

Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathological markers have been proved to have clinical and prognostic value in both non diabetic and diabetic kidney diseases. To discriminate lesions by various degrees of severity, the Working Group of the Renal Pathology Society (RPS) developed a pathologic classification for DKD in 2010. The classification is based on glomerular lesions, with a separate evaluation for interstitial and vascular lesions. In a decade, there were several new characteristics common to DKD, such as the presence of mesangiolysis, glomerular hyalinosis, segmental sclerosis and extracapillary hypercellularity, which have been noted in patients with diabetes and may have prognostic importance. But it is still unclear whether thickening of Bowman's capsule predicts the progression of DKD.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
    1. Age ≥ 18 years old, male or female 2) Patients diagnosed as diabetes kidney disease by renal biopsy
Exclusion Criteria
    1. Patients combined with non diabetes kidney disease; 2) Patients with kidney transplant failure; 3) Patients undergoing zero point puncture for kidney transplantation; 4) less than 5 glomeruli in the renal puncture sample.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
mild thicknening of Bowman's Capsuleno intervention-
severe thickening of Bowman's Capsuleno intervention-
Primary Outcome Measures
NameTimeMethod
renal failureFrom the diagnosis of diabetes kidney disease by renal biopsy to December 31, 2022

estimated glomerular filtration rate(eGFR)\<15ml/min/1.73m2, renal replacement treatment or death caused by renal disease

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath